Trials / Completed
CompletedNCT01750437
Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
Randomized, Double-blind, Active-controlled, Multi-center Phase 2 Clinical Trial to Investigate the Safety, Tolerability and Efficacy of YH1885L in Patients With Non-erosive Reflux Disease(NERD)
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 149 (actual)
- Sponsor
- Yuhan Corporation · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Randomized, double-blind, active-controlled, multi-center phase 2 clinical trial to investigate the safety, tolerability and efficacy of YH1885L in patients with non-erosive reflux disease(NERD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | YH1885L(Revaprazan) | |
| DRUG | Esomeprazole 20mg | |
| DRUG | placebo |
Timeline
- Start date
- 2013-01-01
- Primary completion
- 2013-10-01
- Completion
- 2014-04-01
- First posted
- 2012-12-17
- Last updated
- 2014-07-10
Locations
10 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01750437. Inclusion in this directory is not an endorsement.